Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb has enrolled the first patient in a clinical trial of the enVista MX60EF trifocal IOL, according ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results